1	Lipopolysaccharide	Lipopolysaccharide	B-NP	NN	O	8	SUB
2	from	from	B-PP	IN	O	1	NMOD
3	nonvirulent	nonvirulent	B-NP	JJ	O	7	NMOD
4	Ara+	Ara+	I-NP	JJ	O	7	NMOD
5	Burkholderia	Burkholderia	I-NP	NN	O	7	NMOD
6	pseudomallei	pseudomallei	I-NP	NN	O	7	NMOD
7	isolates	isolate	I-NP	NNS	O	2	PMOD
8	is	be	B-VP	VBZ	O	0	ROOT
9	immunologically	immunologically	B-ADJP	RB	O	10	AMOD
10	indistinguishable	indistinguishable	I-ADJP	JJ	O	8	PRD
11	from	from	B-PP	IN	O	10	AMOD
12	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	11	PMOD
13	from	from	B-PP	IN	O	12	NMOD
14	virulent	virulent	B-NP	JJ	O	16	AMOD
15	Ara-	Ara-	I-NP	JJ	O	16	AMOD
16	clinical	clinical	I-NP	JJ	O	17	NMOD
17	isolates	isolate	I-NP	NNS	O	13	PMOD
18	.	.	O	.	O	8	P

1	Different	Different	B-NP	JJ	O	2	NMOD
2	lines	line	I-NP	NNS	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	evidence	evidence	B-NP	NN	O	3	PMOD
5	suggest	suggest	B-VP	VBP	O	0	ROOT
6	that	that	B-SBAR	IN	O	5	VMOD
7	a	a	B-NP	DT	O	8	NMOD
8	discrepancy	discrepancy	I-NP	NN	O	28	SUB
9	between	between	B-PP	IN	O	8	NMOD
10	the	the	B-NP	DT	O	11	NMOD
11	distribution	distribution	I-NP	NN	O	23	NMOD
12	of	of	B-PP	IN	O	11	NMOD
13	Burkholderia	Burkholderia	B-NP	NNP	O	17	NMOD
14	(	(	O	(	O	17	NMOD
15	Pseudomonas	Pseudomonas	B-NP	NNP	O	17	NMOD
16	)	)	O	)	O	17	NMOD
17	pseudomallei	pseudomallei	B-NP	NNS	O	12	PMOD
18	in	in	B-PP	IN	O	11	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	environment	environment	I-NP	NN	O	18	PMOD
21	and	and	O	CC	O	23	NMOD
22	the	the	B-NP	DT	O	23	NMOD
23	distribution	distribution	I-NP	NN	O	9	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	27	NMOD
26	disease	disease	I-NP	NN	O	27	NMOD
27	melioidosis	melioidosis	I-NP	NN	O	24	PMOD
28	is	be	B-VP	VBZ	O	6	SBAR
29	attributable	attributable	B-ADJP	JJ	O	28	PRD
30	,	,	O	,	O	28	P
31	at	at	B-ADVP	IN	O	33	PMOD
32	least	least	I-ADVP	JJS	O	31	AMOD
33	in	in	B-PP	IN	O	28	VMOD
34	part	part	B-NP	NN	O	33	PMOD
35	,	,	O	,	O	28	P
36	to	to	B-PP	TO	O	28	VMOD
37	phenotypic	phenotypic	B-NP	JJ	O	38	NMOD
38	differences	difference	I-NP	NNS	O	36	PMOD
39	between	between	B-PP	IN	O	38	NMOD
40	clinical	clinical	O	JJ	O	44	NMOD
41	and	and	O	CC	O	44	NMOD
42	some	some	B-NP	DT	O	44	NMOD
43	environmental	environmental	I-NP	JJ	O	44	NMOD
44	isolates	isolate	I-NP	NNS	O	39	PMOD
45	.	.	O	.	O	5	P

1	Two	Two	B-NP	CD	O	6	NMOD
2	antigenically	antigenically	I-NP	RB	O	5	AMOD
3	and	and	O	CC	O	2	AMOD
4	biochemically	biochemically	B-NP	RB	O	5	AMOD
5	distinct	distinct	I-NP	JJ	O	6	NMOD
6	biotypes	biotype	I-NP	NNS	O	7	SUB
7	have	have	B-VP	VBP	O	0	ROOT
8	been	be	I-VP	VBN	O	7	VC
9	described	describe	I-VP	VBN	O	8	VC
10	,	,	O	,	O	7	P
11	only	only	B-NP	RB	O	13	NMOD
12	one	one	I-NP	CD	O	11	AMOD
13	of	of	B-PP	IN	O	7	VMOD
14	which	which	B-NP	WDT	O	13	PMOD
15	is	be	B-VP	VBZ	O	13	SBAR
16	virulent	virulent	B-ADJP	JJ	O	15	PRD
17	.	.	O	.	O	7	P

1	In	In	B-PP	IN	O	9	VMOD
2	this	this	B-NP	DT	O	3	NMOD
3	study	study	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	9	P
5	lipopolysaccharides	lipopolysaccharide	B-NP	NNS	O	9	SUB
6	(	(	O	(	O	8	DEP
7	LPSs	LPS	B-NP	NNS	O	8	DEP
8	)	)	O	)	O	5	NMOD
9	were	be	B-VP	VBD	O	28	VMOD
10	extracted	extract	I-VP	VBN	O	9	VC
11	by	by	B-PP	IN	O	10	VMOD
12	the	the	B-NP	DT	O	16	NMOD
13	proteinase	proteinase	I-NP	NN	O	16	NMOD
14	K	K	I-NP	NN	O	16	NMOD
15	digestion	digestion	I-NP	NN	O	16	NMOD
16	method	method	I-NP	NN	O	11	PMOD
17	from	from	B-PP	IN	O	16	NMOD
18	a	a	B-NP	DT	O	19	NMOD
19	total	total	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	214	214	B-NP	CD	O	24	NMOD
22	B.	B.	I-NP	NNP	O	24	NMOD
23	pseudomallei	pseudomallei	I-NP	NN	O	24	NMOD
24	isolates	isolate	I-NP	NNS	O	20	PMOD
25	,	,	O	,	O	28	P
26	and	and	O	CC	O	28	NMOD
27	their	their	B-NP	PRP$	O	28	NMOD
28	immunoreactivities	immunoreactivity	I-NP	NNS	O	41	SUB
29	with	with	B-PP	IN	O	28	NMOD
30	sera	serum	B-NP	NNS	O	29	PMOD
31	from	from	B-PP	IN	O	30	NMOD
32	patients	patient	B-NP	NNS	O	31	PMOD
33	with	with	B-PP	IN	O	32	NMOD
34	different	different	B-NP	JJ	O	35	AMOD
35	clinical	clinical	I-NP	JJ	O	36	NMOD
36	spectra	spectrum	I-NP	NNS	O	33	PMOD
37	and	and	B-PP	CC	O	31	PMOD
38	with	with	B-PP	IN	O	31	PMOD
39	other	other	B-NP	JJ	O	40	NMOD
40	infections	infection	I-NP	NNS	O	38	PMOD
41	were	be	B-VP	VBD	O	0	ROOT
42	evaluated	evaluate	I-VP	VBN	O	41	VC
43	.	.	O	.	O	41	P

1	With	With	B-PP	IN	O	28	VMOD
2	the	the	B-NP	DT	O	5	NMOD
3	exception	exception	I-NP	NN	O	5	NMOD
4	of4	of4	I-NP	NN	O	5	NMOD
5	isolates	isolate	I-NP	NNS	O	1	PMOD
6	from	from	B-PP	IN	O	5	NMOD
7	a	a	B-NP	DT	O	8	NMOD
8	total	total	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	214	214	B-NP	CD	O	9	PMOD
11	tested	test	B-VP	VBN	O	10	NMOD
12	,	,	O	,	O	28	P
13	the	the	B-NP	DT	O	20	NMOD
14	sodium	sodium	I-NP	NN	O	20	NMOD
15	dodecyl	dodecyl	I-NP	NN	O	20	NMOD
16	sulfate-polyacrylamide	sulfate-polyacrylamide	I-NP	NN	O	20	NMOD
17	gel	gel	I-NP	NN	O	20	NMOD
18	electrophoresis	electrophoresis	I-NP	NN	O	20	NMOD
19	silver-staining	silver-staining	I-NP	JJ	O	20	NMOD
20	profiles	profile	I-NP	NNS	O	28	SUB
21	of	of	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	23	NMOD
23	LPSs	LPS	I-NP	NNS	B-DNA	21	PMOD
24	from	from	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	27	NMOD
26	two	two	I-NP	CD	O	27	NMOD
27	biotypes	biotype	I-NP	NNS	O	24	PMOD
28	showed	show	B-VP	VBD	O	0	ROOT
29	identical	identical	B-NP	JJ	O	31	NMOD
30	ladder	ladder	I-NP	NN	O	31	NMOD
31	patterns	pattern	I-NP	NNS	O	28	OBJ
32	that	that	B-NP	WDT	O	31	NMOD
33	were	be	B-VP	VBD	O	32	SBAR
34	typical	typical	B-ADJP	JJ	O	33	PRD
35	for	for	B-PP	IN	O	34	AMOD
36	smooth	smooth	B-NP	JJ	O	37	NMOD
37	LPSs	LPS	I-NP	NNS	O	35	PMOD
38	from	from	B-PP	IN	O	37	NMOD
39	other	other	B-NP	JJ	O	41	NMOD
40	gram-negative	gram-negative	I-NP	JJ	O	41	NMOD
41	bacteria	bacteria	I-NP	NNS	O	38	PMOD
42	.	.	O	.	O	28	P

1	The	The	B-NP	DT	O	3	NMOD
2	210	210	I-NP	CD	O	3	NMOD
3	isolates	isolate	I-NP	NNS	O	31	SUB
4	with	with	B-PP	IN	O	3	NMOD
5	typical	typical	B-NP	JJ	O	7	NMOD
6	LPS	LPS	I-NP	NN	O	7	NMOD
7	patterns	pattern	I-NP	NNS	O	4	PMOD
8	(	(	O	(	O	29	DEP
9	119	119	B-NP	CD	O	10	NMOD
10	Ara-	Ara-	I-NP	NN	O	28	NMOD
11	clinical	clinical	B-ADJP	JJ	O	28	NMOD
12	,	,	O	,	O	28	P
13	13	13	B-NP	CD	O	15	NMOD
14	Ara-	Ara-	I-NP	JJ	O	15	NMOD
15	soil	soil	I-NP	NN	O	28	NMOD
16	,	,	O	,	O	28	P
17	70	70	B-NP	CD	O	19	NMOD
18	Ara+	Ara+	I-NP	JJ	O	19	NMOD
19	soil	soil	I-NP	NN	O	28	NMOD
20	,	,	O	,	O	28	P
21	and	and	O	CC	O	28	NMOD
22	8	8	B-NP	CD	O	28	NMOD
23	reference	reference	I-NP	NN	O	28	NMOD
24	National	National	I-NP	NNP	O	28	NMOD
25	Type	Type	I-NP	NNP	O	28	NMOD
26	Culture	Culture	I-NP	NNP	O	28	NMOD
27	Collection	Collection	I-NP	NNP	O	28	NMOD
28	strains	strain	I-NP	NNS	O	29	DEP
29	)	)	O	)	O	7	NMOD
30	also	also	B-ADVP	RB	O	31	VMOD
31	exhibited	exhibit	B-VP	VBD	O	0	ROOT
32	similar	similar	B-NP	JJ	O	34	NMOD
33	immunoblot	immunoblot	I-NP	NN	O	34	NMOD
34	profiles	profile	I-NP	NNS	O	31	OBJ
35	against	against	B-PP	IN	O	31	VMOD
36	pooled	pooled	B-NP	JJ	O	37	NMOD
37	sera	serum	I-NP	NNS	O	35	PMOD
38	from	from	B-PP	IN	O	37	NMOD
39	patients	patient	B-NP	NNS	O	38	PMOD
40	with	with	B-PP	IN	O	39	NMOD
41	melioidosis	melioidosis	B-NP	NN	O	45	NMOD
42	and	and	O	CC	O	45	NMOD
43	hyperimmune	hyperimmune	B-NP	JJ	O	45	NMOD
44	mouse	mouse	I-NP	NN	O	45	NMOD
45	sera	serum	I-NP	NNS	O	40	PMOD
46	.	.	O	.	O	31	P

1	Concordant	Concordant	B-NP	JJ	O	2	NMOD
2	findings	finding	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	noted	note	I-VP	VBN	O	3	VC
5	in	in	B-PP	IN	O	4	VMOD
6	the	the	B-NP	DT	O	10	NMOD
7	indirect	indirect	I-NP	JJ	O	10	NMOD
8	enzyme-linked	enzyme-linked	I-NP	JJ	O	10	NMOD
9	immunosorbent	immunosorbent	I-NP	JJ	O	10	NMOD
10	assay	assay	I-NP	NN	O	5	PMOD
11	with	with	B-PP	IN	O	4	VMOD
12	Ara-	Ara-	B-NP	NN	O	15	NMOD
13	and	and	O	CC	O	15	NMOD
14	Ara+	Ara+	B-NP	JJ	O	15	NMOD
15	LPSs	LPS	I-NP	NNS	O	11	PMOD
16	to	to	B-VP	TO	O	17	VMOD
17	coat	coat	I-VP	VB	O	4	VMOD
18	the	the	B-NP	DT	O	19	NMOD
19	microtiter	microtiter	I-NP	NN	O	17	OBJ
20	plates	plat	B-VP	VBZ	O	17	VMOD
21	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	LPSs	LPS	I-NP	NNS	O	9	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	8	NMOD
5	different	different	I-NP	JJ	O	8	NMOD
6	B.	B.	I-NP	NNP	O	8	NMOD
7	pseudomallei	pseudomallei	I-NP	NN	O	8	NMOD
8	biotypes	biotype	I-NP	NNS	O	3	PMOD
9	appear	appear	B-VP	VBP	O	0	ROOT
10	antigenically	antigenically	B-ADJP	RB	O	11	AMOD
11	indistinguishable	indistinguishable	I-ADJP	JJ	O	9	PRD
12	.	.	O	.	O	9	P

1	It	It	B-NP	PRP	O	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	,	,	O	,	O	2	P
4	therefore	therefore	B-ADVP	RB	O	2	VMOD
5	,	,	O	,	O	2	P
6	unlikely	unlikely	B-ADJP	JJ	O	2	PRD
7	that	that	B-SBAR	IN	O	2	VMOD
8	this	this	B-NP	DT	O	9	NMOD
9	component	component	I-NP	NN	O	10	SUB
10	is	be	B-VP	VBZ	O	7	SBAR
11	related	related	B-ADJP	JJ	O	10	PRD
12	to	to	B-PP	TO	O	11	AMOD
13	the	the	B-NP	DT	O	16	NMOD
14	virulence	virulence	I-NP	NN	O	16	NMOD
15	and	and	I-NP	CC	O	16	NMOD
16	pathogenicity	pathogenicity	I-NP	NN	O	12	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	B.	B.	B-NP	NNP	O	19	NMOD
19	pseudomallei	pseudomallei	I-NP	NNP	O	17	PMOD
20	.	.	O	.	O	2	P

